Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 46

1.

One-Year Outcomes of Transcatheter Aortic Valve Replacement in Patients With End-Stage Renal Disease.

O'Hair DP, Bajwa TK, Chetcuti SJ, Deeb GM, Stoler RC, Hebeler RF, Maini B, Mumtaz M, Kleiman NS, Reardon MJ, Li S, Adams DH, Watson DR, Yakubov SJ, Popma JJ, Petrossian G.

Ann Thorac Surg. 2017 Feb 24. pii: S0003-4975(16)31795-7. doi: 10.1016/j.athoracsur.2016.11.061. [Epub ahead of print]

PMID:
28242075
2.

Neurological Events Following Transcatheter Aortic Valve Replacement and Their Predictors: A Report From the CoreValve Trials.

Kleiman NS, Maini BJ, Reardon MJ, Conte J, Katz S, Rajagopal V, Kauten J, Hartman A, McKay R, Hagberg R, Huang J, Popma J; CoreValve Investigators..

Circ Cardiovasc Interv. 2016 Sep;9(9). pii: e003551. doi: 10.1161/CIRCINTERVENTIONS.115.003551.

PMID:
27601429
3.

Outcomes in the Randomized CoreValve US Pivotal High Risk Trial in Patients With a Society of Thoracic Surgeons Risk Score of 7% or Less.

Reardon MJ, Kleiman NS, Adams DH, Yakubov SJ, Coselli JS, Deeb GM, O'Hair D, Gleason TG, Lee JS, Hermiller JB Jr, Chetcuti S, Heiser J, Merhi W, Zorn GL 3rd, Tadros P, Robinson N, Petrossian G, Hughes GC, Harrison JK, Maini B, Mumtaz M, Conte JV, Resar JR, Aharonian V, Pfeffer T, Oh JK, Huang J, Popma JJ.

JAMA Cardiol. 2016 Nov 1;1(8):945-949. doi: 10.1001/jamacardio.2016.2257.

PMID:
27541162
4.

Transcatheter Mitral Valve Replacement in Native Mitral Valve Disease With Severe Mitral Annular Calcification: Results From the First Multicenter Global Registry.

Guerrero M, Dvir D, Himbert D, Urena M, Eleid M, Wang DD, Greenbaum A, Mahadevan VS, Holzhey D, O'Hair D, Dumonteil N, Rodés-Cabau J, Piazza N, Palma JH, DeLago A, Ferrari E, Witkowski A, Wendler O, Kornowski R, Martinez-Clark P, Ciaburri D, Shemin R, Alnasser S, McAllister D, Bena M, Kerendi F, Pavlides G, Sobrinho JJ, Attizzani GF, George I, Nickenig G, Fassa AA, Cribier A, Bapat V, Feldman T, Rihal C, Vahanian A, Webb J, O'Neill W.

JACC Cardiovasc Interv. 2016 Jul 11;9(13):1361-71. doi: 10.1016/j.jcin.2016.04.022.

PMID:
27388824
5.

Native Mitral Stenosis Treated With Transcatheter Mitral Valve Replacement.

Jain R, Algahim MF, Bajwa TK, Khandheria BK, O'Hair DP.

Ann Thorac Surg. 2016 Mar;101(3):e75-7. doi: 10.1016/j.athoracsur.2015.09.020.

PMID:
26897235
6.

Three-dimensional echocardiography guidance in case of papillary fibroelastoma complicating transaortic valve implantation.

Jain R, Bajwa T, O'Hair D, Khandheria BK.

Eur Heart J Cardiovasc Imaging. 2015 May;16(5):570. doi: 10.1093/ehjci/jev016. No abstract available.

PMID:
25711354
7.

Transcatheter aortic-valve replacement with a self-expanding prosthesis.

Adams DH, Popma JJ, Reardon MJ, Yakubov SJ, Coselli JS, Deeb GM, Gleason TG, Buchbinder M, Hermiller J Jr, Kleiman NS, Chetcuti S, Heiser J, Merhi W, Zorn G, Tadros P, Robinson N, Petrossian G, Hughes GC, Harrison JK, Conte J, Maini B, Mumtaz M, Chenoweth S, Oh JK; U.S. CoreValve Clinical Investigators..

N Engl J Med. 2014 May 8;370(19):1790-8. doi: 10.1056/NEJMoa1400590.

8.

Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery.

Popma JJ, Adams DH, Reardon MJ, Yakubov SJ, Kleiman NS, Heimansohn D, Hermiller J Jr, Hughes GC, Harrison JK, Coselli J, Diez J, Kafi A, Schreiber T, Gleason TG, Conte J, Buchbinder M, Deeb GM, Carabello B, Serruys PW, Chenoweth S, Oh JK; CoreValve United States Clinical Investigators..

J Am Coll Cardiol. 2014 May 20;63(19):1972-81. doi: 10.1016/j.jacc.2014.02.556.

9.

4-year results of a randomized controlled trial of percutaneous repair versus surgery for mitral regurgitation.

Mauri L, Foster E, Glower DD, Apruzzese P, Massaro JM, Herrmann HC, Hermiller J, Gray W, Wang A, Pedersen WR, Bajwa T, Lasala J, Low R, Grayburn P, Feldman T; EVEREST II Investigators..

J Am Coll Cardiol. 2013 Jul 23;62(4):317-28. doi: 10.1016/j.jacc.2013.04.030.

10.

Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation.

Aaronson KD, Slaughter MS, Miller LW, McGee EC, Cotts WG, Acker MA, Jessup ML, Gregoric ID, Loyalka P, Frazier OH, Jeevanandam V, Anderson AS, Kormos RL, Teuteberg JJ, Levy WC, Naftel DC, Bittman RM, Pagani FD, Hathaway DR, Boyce SW; HeartWare Ventricular Assist Device (HVAD) Bridge to Transplant ADVANCE Trial Investigators..

Circulation. 2012 Jun 26;125(25):3191-200. doi: 10.1161/CIRCULATIONAHA.111.058412.

11.

What went wrong and how it got right: heart team provides value in transcatheter aortic valve replacement.

Todaro MC, Oreto L, Bajwa T, O'Hair D, Khandheria BK.

Eur Heart J Cardiovasc Imaging. 2012 Oct;13(10):807. doi: 10.1093/ehjci/jes092. No abstract available.

PMID:
22552049
12.

Case of the mysterious signal.

Oreto L, Todaro MC, Bajwa T, Kostopoulos L, O'Hair D, Khandheria BK.

Eur Heart J Cardiovasc Imaging. 2012 Jun;13(6):536. doi: 10.1093/ehjci/jer312. No abstract available.

PMID:
22271111
13.

Organized granulation tissue mimicking left atrial myxoma recurrence.

Keating VP, Ammar KA, Knoedler DM, O'Hair DP, Port SC.

Circulation. 2011 Oct 18;124(16):e409-10. doi: 10.1161/CIRCULATIONAHA.111.033167. No abstract available.

14.

Percutaneous repair or surgery for mitral regurgitation.

Feldman T, Foster E, Glower DD, Kar S, Rinaldi MJ, Fail PS, Smalling RW, Siegel R, Rose GA, Engeron E, Loghin C, Trento A, Skipper ER, Fudge T, Letsou GV, Massaro JM, Mauri L; EVEREST II Investigators..

N Engl J Med. 2011 Apr 14;364(15):1395-406. doi: 10.1056/NEJMoa1009355. Erratum in: N Engl J Med. 2011 Jul 14;365(2):189. Glower, Donald G [corrected to Glower, Donald D].

15.

Advanced heart failure treated with continuous-flow left ventricular assist device.

Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D, Sun B, Tatooles AJ, Delgado RM 3rd, Long JW, Wozniak TC, Ghumman W, Farrar DJ, Frazier OH; HeartMate II Investigators..

N Engl J Med. 2009 Dec 3;361(23):2241-51. doi: 10.1056/NEJMoa0909938.

16.

Research traditions in provider-consumer interaction: implications for cancer care.

O'Hair D.

Patient Educ Couns. 2003 May;50(1):5-8. Review.

PMID:
12767576
17.

Cancer survivorship and agency model: implications for patient choice, decision making, and influence.

O'Hair D, Villagran MM, Wittenberg E, Brown K, Ferguson M, Hall HT, Doty T.

Health Commun. 2003;15(2):193-202.

PMID:
12742770
18.

Transseptal guidewire stabilization facilitates stent-graft deployment for persistent proximal ascending aortic dissection.

Dorros G, Dorros AM, Planton S, O'Hair D, Zayed M.

J Endovasc Ther. 2000 Dec;7(6):506-12.

PMID:
11194823
19.

Open versus endoscopic saphenous vein harvesting: wound complications and vein quality.

Crouch JD, O'Hair DP, Keuler JP, Barragry TP, Werner PH, Kleinman LH.

Ann Thorac Surg. 1999 Oct;68(4):1513-6.

PMID:
10543557
20.

Salvage by volume reduction of chronic allograft rejection in emphysema.

Schulman LL, O'Hair DP, Cantu E, McGregor C, Ginsberg ME.

J Heart Lung Transplant. 1999 Feb;18(2):107-12.

PMID:
10194032

Supplemental Content

Loading ...
Support Center